What Is an IV Iron Infusion Made Of?

An IV iron infusion is, at its core, a tiny engineered particle: a cluster of iron atoms wrapped in a sugar-based shell, suspended in a sterile solution. These nanoparticles are designed so that the iron inside them is released slowly and safely into your bloodstream, rather than flooding it all at once. The specific type of sugar coating varies from one product to another, and that coating turns out to be the single most important difference between the various IV iron drugs on the market.

The Basic Architecture of IV Iron

Every IV iron product shares the same fundamental design. At the center sits a core of iron in its oxidized form, technically an iron(III)-oxyhydroxide or iron oxide mineral. Surrounding that core is a carbohydrate ligand, essentially a shell made of sugar-like molecules that keeps the iron locked in place until your body is ready to use it.¹ The result is a colloidal suspension, meaning the particles are small enough to stay evenly distributed in the liquid rather than settling to the bottom of the bag.

This design did not come about by accident. The earliest attempts at giving iron intravenously used uncomplexed iron salts, basically raw dissolved iron with no protective coating. Those formulations caused severe and sometimes fatal toxicity because free iron is highly reactive in the body, generating harmful molecules that damage tissues.² The invention of colloidal iron-carbohydrate complexes solved that problem by releasing iron gradually, mimicking the way your body normally stores and transports iron rather than dumping it into your blood all at once.

What Makes Each Formulation Different

If all IV iron drugs have an iron core wrapped in a carbohydrate shell, you might wonder why there are so many different products. The answer is that the shell matters enormously. The type of carbohydrate used to coat the iron core affects how tightly the iron is held, how quickly it gets released, how the immune system responds to the particle, and how large a dose can be given in a single sitting.¹ The carbohydrate ligand is essentially a unique fingerprint for each drug.

The IV iron formulations you are most likely to encounter include:

Iron sucrose: Uses sucrose (table sugar) as the shell. It has a relatively low molecular weight and moderate stability, which means it tends to be given in smaller, more frequent doses, often around 200 mg per session.
Sodium ferric gluconate: Uses gluconate in a sucrose solution as its coating. Like iron sucrose, it typically requires multiple smaller infusions to reach a full replacement dose.³
Ferric carboxymaltose: Uses a carboxymaltose shell that binds iron very tightly. This high stability allows a large dose (up to 750 mg or sometimes 1,000 mg) to be given in a single infusion without overwhelming the body’s ability to process it.⁴
Ferric derisomaltose: Uses an isomaltoside shell. Also a high-stability formulation, and like ferric carboxymaltose, it can deliver a large dose in one session, sometimes up to 1,000 mg or more.⁴
Ferumoxytol: Contains a superparamagnetic iron oxide core coated with a polyglucose sorbitol carboxymethylether shell. Originally approved for treating iron deficiency anemia in chronic kidney disease patients, it has an unusually robust carbohydrate coating and can also be administered as a large single dose.⁵

All five share the same basic iron-core-plus-carbohydrate-shell blueprint, but the practical differences between them, from how many infusion visits you need to what side effects are most likely, stem almost entirely from the chemistry of their coatings.

Why Shell Stability Determines the Dose

When an IV iron nanoparticle enters your bloodstream, a race begins. Your body’s immune cells, particularly macrophages in the liver, spleen, and bone marrow, engulf these particles and begin stripping away the carbohydrate shell to get at the iron inside. The iron is then either stored within those cells as ferritin or handed off to a transport protein called transferrin, which shuttles it to wherever your body needs it most, usually the bone marrow, where red blood cells are made.

The tighter the carbohydrate shell grips the iron core, the more slowly iron is released from the nanoparticle after macrophages take it up. That controlled release is the key safety feature. The degradation speed and therefore the safety of a given IV iron product are directly tied to the molecular weight and stability of the complex.⁶ A loosely bound shell lets iron escape quickly, which can overwhelm the body’s transport system and leave free iron circulating in the blood. Free iron catalyzes the production of reactive oxygen species, damaging cells and tissues. A tightly bound shell keeps the iron locked up until the body’s own machinery can handle it.

This is why formulations with more stable shells, such as ferric carboxymaltose and ferric derisomaltose, can be given at high doses in a single visit without causing the toxicity associated with large amounts of free iron. Older, less stable formulations require multiple smaller infusions spread over weeks to achieve the same total dose safely.

What Else Is in the Bag

The iron nanoparticles are not the only ingredient in your infusion. Before administration, the concentrated IV iron product is typically diluted in a bag of normal saline (a 0.9% sodium chloride solution) or, for some formulations, in a dextrose solution. The total volume you receive, usually somewhere between 100 and 250 mL depending on the product, is mostly this carrier fluid. The nanoparticles themselves make up a tiny fraction of the volume but contain all the therapeutic iron.

Each product also contains buffering agents and pH adjusters to keep the solution stable during storage and compatible with your blood once infused. The exact inactive ingredients vary by manufacturer, and product labels list them in detail. For people with known sensitivities to specific sugars or additives, these excipients can occasionally matter. If you have a rare allergy to a carbohydrate used in one formulation, your doctor can often switch to a product with a different shell chemistry.

Reactions and What Causes Them

One of the most common concerns people have about IV iron is the risk of an allergic reaction. The reassuring news is that serious reactions are uncommon with modern formulations. The more interesting news is that when reactions do happen, the mechanism is often not a true allergy in the classical sense. Research suggests that complement activation-related pseudo-allergy, triggered by the iron nanoparticles interacting with the complement system (a branch of your immune defenses), is probably a more frequent cause of acute reactions to current IV iron products than a genuine antibody-mediated allergic response.⁷

In practical terms, this means symptoms like flushing, chest tightness, back pain, or a drop in blood pressure during or shortly after an infusion are often not caused by an immune memory response to iron. Instead, the nanoparticles themselves can activate complement proteins in your blood, which triggers inflammation-like symptoms. This distinction matters because a complement-mediated reaction does not necessarily mean you can never receive IV iron again, though your medical team will want to manage the situation carefully and may switch to a different formulation or slow the infusion rate.

Milder side effects, such as temporary nausea, headache, or a metallic taste in the mouth, are more common and tend to resolve on their own. Infusion centers routinely monitor patients during and shortly after the infusion to catch any issues early.

The Phosphate Problem

A side effect that has received increasing attention in recent years is hypophosphatemia, a drop in blood phosphate levels after IV iron treatment. This is not a general risk of all IV iron products; it is especially associated with ferric carboxymaltose and, to a lesser degree, with some other formulations.⁸

The mechanism involves a hormone called fibroblast growth factor 23, or FGF23. Certain IV iron formulations trigger an increase in the active form of FGF23, which tells the kidneys to dump phosphate into the urine. The result is that blood phosphate levels can plummet, sometimes to clinically significant lows.⁹ Low phosphate causes fatigue, muscle weakness, and bone pain, and when severe or prolonged, it can lead to a bone-softening condition called osteomalacia. This is particularly concerning for people who need repeated IV iron infusions over months or years.

Clinicians have sometimes missed this side effect because the symptoms overlap with the iron deficiency that prompted treatment in the first place. If you are still feeling exhausted after your iron levels have improved, low phosphate is worth investigating. A simple blood test can check for it, and your doctor may consider switching you to a formulation with a lower risk of this effect, such as ferric derisomaltose, which appears to cause less FGF23 elevation than ferric carboxymaltose.

Why These Drugs Are Hard to Copy

IV iron products are classified as non-biological complex drugs. That label reflects something unusual about their nature: their therapeutic behavior depends not just on their chemical formula but on the size, shape, and surface properties of the nanoparticles, features that are extremely difficult to replicate exactly.¹⁰ The characterization of these drugs requires sophisticated techniques because standard chemical analysis alone cannot fully predict how they will behave in the body.¹¹

This is relevant to you because it means that a “generic” IV iron product is not the same thing as a generic version of, say, ibuprofen. With a small-molecule drug, a generic manufacturer just needs to match the chemical formula. With an IV iron nanoparticle, the manufacturing process itself shapes the final product’s properties. Tiny differences in how the iron core crystallizes, how the carbohydrate shell wraps around it, or how large the particles end up being can affect how quickly iron is released, how the immune system responds, and ultimately how safe and effective the drug is. Regulatory agencies in different countries take varying approaches to approving these similar-but-not-identical copies, which sometimes leads to differences in what is available depending on where you live.

Ferumoxytol and MRI Scans

Ferumoxytol has an interesting quirk that sets it apart from other IV iron formulations. Its superparamagnetic iron oxide core is strongly magnetic, which means it shows up vividly on MRI scans and can create artifacts that interfere with imaging.¹² Researchers have actually explored repurposing ferumoxytol as an MRI contrast agent in addition to its primary role as an anemia treatment.⁵

If you have received a ferumoxytol infusion and need an MRI soon afterward, this is worth mentioning to the imaging team. The magnetic properties of the circulating nanoparticles can distort signal on multiple brain and body sequences, potentially mimicking or obscuring real findings. The effect diminishes as your body clears the particles and incorporates the iron into normal stores, but for weeks to months after an infusion, MRI interpretation can be tricky. Other IV iron formulations do not share this property to any clinically meaningful degree, so this concern is specific to ferumoxytol.

Oral Iron Versus IV Iron

Understanding what IV iron is made of helps explain why it exists as an alternative to iron pills, not just a fancier version of them. Oral iron supplements contain simple iron salts, often ferrous sulfate or ferrous gluconate, which dissolve in your stomach and are absorbed through the gut lining. That process is slow, inefficient, and hard on the digestive tract, causing nausea, constipation, or stomach cramps in a large number of people.

IV iron bypasses the gut entirely. The nanoparticles go straight into the bloodstream and are taken up by macrophages, which process the iron on their own schedule. High-dose formulations like ferric carboxymaltose and ferric derisomaltose can deliver in one or two infusion sessions what might take months of daily oral supplements to achieve, and they tend to be better tolerated than oral iron in terms of gastrointestinal side effects.⁴ That said, IV iron carries its own unique risks, including the infusion reactions and phosphate issues discussed above, which oral iron does not cause. It also requires a medical visit rather than a trip to the pharmacy. For mild iron deficiency in someone who can tolerate pills, oral iron is usually tried first. IV iron tends to be reserved for people whose anemia is more severe, who cannot absorb oral iron well due to conditions like inflammatory bowel disease or after certain surgeries, or who simply cannot tolerate the side effects of iron pills.

How Long the Iron Lasts

Once the iron from your infusion has been processed by macrophages and released into your body’s iron stores, it behaves like any other iron. It gets incorporated into hemoglobin in new red blood cells, stored as ferritin in the liver and other organs, or used by enzymes throughout the body. The infusion is not a permanent fix for iron deficiency; it refills your stores, but if the underlying cause of the deficiency persists, such as heavy menstrual bleeding, chronic kidney disease, or ongoing poor absorption, your levels will eventually drop again and you may need repeat infusions.

How quickly you notice improvement depends on what symptoms brought you to the infusion chair. Some people feel more energetic within a few days, likely because iron-dependent enzymes in muscles and other tissues get replenished quickly. Hemoglobin levels, however, take longer to respond because new red blood cells need to be manufactured in the bone marrow, a process that plays out over weeks. Most clinicians check lab values about four to eight weeks after an infusion to see how well your stores have recovered. If your ferritin and hemoglobin have not budged meaningfully by then, something else may be going on, and further investigation is warranted.